AI News: Google, OpenAI, Pharma

Discover the Pharma AI Shake-Up!

Hello Tensor Black Fans!

Exciting developments in AI last week saw OpenAI entering the search fray to compete with Google, a pharma giant walking away from Microsoft's AI, and Google taking over the leaderboard with its new AI prodigy.

Read on to Level Up:

  • Google's Multisearch Revolution

  • Google's Gemini: New AI Prodigy

  • AI Search Revolution

  • Every Business on AI Wave

  • Pharma Giant Rejects Copilot AI

Have a great week,
The TensorBlack Team

We asked ChatGPT to try its hand at our weekly newsletter! (learn more).

OpenAI writing a weekly newsletter with its new SearchGPT

Summarize the latest AI developments in oncology from the past week. Select no more than five articles, providing their publication dates. For each article, include the following sections: a catchy headline, a brief description of the development, why it matters for oncology and cancer care, and a citation for each source. Additionally, create an image prompt suitable for highlighting the given article, in the style of Scientific American or the New York Times.

— TensorBlack Team

What’s Hot

Google is revolutionizing search with its desktop Chrome update, introducing multisearch for text and images, a search history question tool, and a product comparison feature.

OpenAI Imagining Chrome’s Circle-to-Search

Details:

  • Multisearch allows simultaneous text and image searches, with results displayed in the viewing tab's sidebar.

  • The question tool uses AI to enable queries about search history, improving link retrieval.

  • An upcoming feature will assist in comparing products for online shopping.

Why it Matters

Busy healthcare professionals would be able to retrieve information more quickly with the new multisearch and search history query tool.

Google's Gemini 1.5 Pro has outshone GPT-4o and Claude-3, grabbing the pole in generative AI benchmarks.

Stable Diffusion Imagining the Dawn of Google Gemini Flash

Details

  • Gemini 1.5 Pro scored 1,300 on LMSYS Chatbot Arena, leaving behind GPT-4o's 1,286 and Claude-3's 1,271.

  • Despite the notable performance, Google may adjust or even withdraw this model due to its early release status.

  • OpenAI and Anthropic's response to this tough competitor is eagerly anticipated.

Why it Matters

Improved AI models like Gemini 1.5 Pro could enhance patient care by mimicking human-like conversation, making virtual patient engagement more effective.

OpenAI's new SearchGPT integrates real-time internet information into ChatGPT, streamlining search efforts.

ChatGPT-4o Imagines Oncologists using SearchGPT

Details

  • SearchGPT combines chatbot technology with real-time web information for faster, easier searches.

  • Publishers like Reuters collaborate with OpenAI to ensure high-quality content integration.

  • OpenAI is developing ways for publishers to manage their presence in SearchGPT results.

Why it Matters

This innovation can save oncologists and caregivers time by providing up-to-date, reliable information quickly, helping them stay informed about the latest advancements without additional research effort.

Huang and Zuckerberg predict the future of businesses will universally incorporate AI, as they launch and exhibit advanced open-source AI models and platforms respectively.

Mark Zuckerberg talking about an AI for Every Business

Details

  • Meta CEO, Mark Zuckerberg, announced AI Studio which facilitates the creation and discovery of AI characters.

  • NVIDIA CEO, Jensen Huang, showcased the digital human "James", capable of delivering contextual responses.

  • The potential of AI has been highlighted, envisioning a future where AI could create real-time images as users type.

Why it Matters

We once thought having a personal phone-number was crazy, too. Soon the Internet will have billions of AIs that interact with us and each other.

A high-priced AI fails to impress a pharma giant, resonating "middle-school presentations.”

Fooocus imagines a pharma executive displeased with AI’s middle school talk

Details

  • Pharma company canceled Microsoft's Office 365 Copilot AI due to high costs and poor value.

  • The CIO criticized the tool's low-quality results, reminiscent of "middle-school presentations". 

  • Microsoft is reconsidering its licensing scheme to justify the AI's cost.

Why it Matters

  • AI integrations, even from tech leaders, may not always meet industry-specific needs.

  • It emphasizes the importance of cost and value analysis in evaluating AI solutions for health industries.